x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 538)	Pediatric Primary Tumors	538	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		3.89	3.97	0	1.36	2.63	4.84	28.36
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 168)	Pediatric Primary Tumors	168	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		4.76	5.92	0.03	0.9	2.82	6.34	36.98
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 40)	Pediatric Primary Tumors	40	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		1.4	2.53	0.08	0.4	0.58	1.37	14.83
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 45)	Pediatric Primary Tumors	45	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		3.7	5.9	0	1.34	2.09	2.91	35.71
Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)	Pediatric Primary Tumors	6	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Chordoma		MONDO_0008978	MONDO_0008978		1.13	0.72	0.18	0.62	1.15	1.71	1.98
Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Choroid plexus carcinoma		MONDO_0016718	MONDO_0016718		5.81	11.43	0.43	0.62	0.98	2.15	36.33
Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 25)	Pediatric Primary Tumors	25	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Choroid plexus papilloma		EFO_1000177	MONDO_0009837		1.8	1.81	0.16	0.79	1.09	2.49	8.19
Clear cell sarcoma of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 13)	Pediatric Primary Tumors	13	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Clear cell sarcoma of the kidney		EFO_0000350	MONDO_0005006		2.32	0.73	1.02	1.91	2.23	2.84	3.3
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 12)	Pediatric Primary Tumors	12	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		9.23	12.4	0.43	1.05	2.82	12.07	37.02
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 17)	Pediatric Primary Tumors	17	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		0.45	0.42	0.06	0.17	0.31	0.69	1.46
Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse intrinsic pontine glioma		EFO_1000026	MONDO_0006033		0.83	1.28	0.1	0.14	0.23	0.92	2.74
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)	Pediatric Primary Tumors	116	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		4.07	6.42	0	0.78	1.57	3.79	35.27
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)	Pediatric Primary Tumors	31	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		0.43	1.17	0.01	0.11	0.14	0.26	6.46
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		2.81	2.14	0.88	1.11	2.51	4.2	5.32
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)	Pediatric Primary Tumors	116	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		0.7	1.16	0.01	0.12	0.34	0.82	8.92
Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ewing sarcoma		EFO_0000174	MONDO_0012817		1.36	0.65	0.72	0.87	1.09	1.77	2.63
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 64)	Pediatric Primary Tumors	64	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		0.4	0.99	0.02	0.13	0.23	0.35	7.95
Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 45)	Pediatric Primary Tumors	45	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		2.11	2.18	0.08	0.63	1.03	2.95	8.98
Ganglioneuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 26)	Pediatric Primary Tumors	26	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	GMKF	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		2.18	2.64	0.18	0.64	0.92	2.64	10.47
Ganglioneuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 20)	Pediatric Primary Tumors	20	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		2.75	2.39	0.12	0.62	2.29	4.27	8.98
Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 8)	Pediatric Primary Tumors	8	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Germinoma		MONDO_0020580	MONDO_0020580		5.06	6.69	0.55	1.32	2.9	4.47	20.79
Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 19)	Pediatric Primary Tumors	19	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Glial-neuronal tumor NOS		MONDO_0016729	MONDO_0016729		1.24	2.37	0.02	0.1	0.25	0.68	8.16
Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Hemangioblastoma		MONDO_0016748	MONDO_0016748		0.36	0.22	0.16	0.26	0.31	0.42	0.68
High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 95)	Pediatric Primary Tumors	95	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	High-grade glioma		MONDO_0100342	MONDO_0100342		5.19	8.72	0.07	1.01	2.11	5.5	57.89
High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 29)	Pediatric Primary Tumors	29	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	High-grade glioma/astrocytoma		MONDO_0016680	MONDO_0016680		1.82	1.98	0.01	0.34	1.13	2.82	7.29
Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)	Pediatric Primary Tumors	6	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Infant-type hemispheric glioma		EFO_0005543	MONDO_0014695		0.42	0.38	0.15	0.27	0.28	0.36	1.18
Langerhans Cell histiocytosis  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)	Pediatric Primary Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Langerhans Cell histiocytosis		EFO_1000318	MONDO_0018310		1.18	0.58	0.44	0.91	1.2	1.32	2.02
Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 329)	Pediatric Primary Tumors	329	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Low-grade glioma		MONDO_0021637	MONDO_0021637		0.47	0.87	0	0.13	0.23	0.43	7.69
Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 15)	Pediatric Primary Tumors	15	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		0.66	0.88	0.06	0.14	0.6	0.7	3.53
Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)	Pediatric Primary Tumors	3	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Malignant peripheral nerve sheath tumor		EFO_0000760	MONDO_0017827		0.85	0.8	0.33	0.39	0.45	1.11	1.77
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 206)	Pediatric Primary Tumors	206	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		4.48	10.86	0.12	1.2	1.84	3.31	115.46
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)	Pediatric Primary Tumors	31	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Meningioma		MONDO_0016642	MONDO_0016642		0.92	2.9	0	0.22	0.29	0.46	16.37
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 304)	Pediatric Primary Tumors	304	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		3.6	2.77	0.1	1.68	3	4.91	21.06
Neuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 183)	Pediatric Primary Tumors	183	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	GMKF	Neuroblastoma		EFO_0000621	MONDO_0005072		3.37	2.35	0.14	1.85	2.98	4.78	19.81
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 129)	Pediatric Primary Tumors	129	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		3.95	3.26	0.1	1.54	3.06	5.41	21.06
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 14)	Pediatric Primary Tumors	14	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.37	0.41	0.02	0.15	0.24	0.39	1.67
Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Non-germinomatous germ cell tumor		MONDO_0020580	MONDO_0020580		4.29	4.38	0.13	0.69	4.47	8.06	8.09
Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 20)	Pediatric Primary Tumors	20	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Oligodendroglioma		EFO_0000632	MONDO_0016695		0.52	0.89	0.02	0.15	0.32	0.49	4.19
Osteosarcoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 87)	Pediatric Primary Tumors	87	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Osteosarcoma		EFO_0000637	MONDO_0009807		3.11	3.86	0.45	1.47	2.15	3.43	32.2
Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pineoblastoma		EFO_1000475	MONDO_0016722		5.87	8.57	0.26	1.01	2.22	4.06	25.01
Rhabdoid tumor of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 64)	Pediatric Primary Tumors	64	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Rhabdoid tumor of the kidney		EFO_1000512	MONDO_0002729		2.99	1.9	0	1.42	2.69	4.42	8.13
Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)	Pediatric Primary Tumors	7	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Sarcoma		EFO_0000691	MONDO_0005089		1.3	1.34	0.09	0.64	0.95	1.33	4.16
Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)	Pediatric Primary Tumors	23	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Schwannoma		EFO_0000693	MONDO_0002546		0.45	0.35	0.1	0.2	0.39	0.56	1.73
Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)	Pediatric Primary Tumors	5	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Subependymal Giant Cell Astrocytoma		MONDO_0016693	MONDO_0016693		0.66	0.4	0.23	0.48	0.56	0.71	1.31
Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)	Pediatric Primary Tumors	6	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	PBTA	Teratoma		MONDO_0002601	MONDO_0002601		0.96	0.9	0.16	0.28	0.6	1.58	2.29
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 124)	Pediatric Primary Tumors	124	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		5.7	3.82	0.36	2.57	4.92	7.72	20.45
Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)	TCGA Primary Tumors	147	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		15.44	8.05	1.64	9.92	14.82	19.06	55.63
Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)	TCGA Primary Tumors	77	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Adrenocortical Carcinoma		EFO_1000796	MONDO_0006639		0.96	1.03	0.02	0.28	0.51	1.44	5.41
Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)	TCGA Primary Tumors	405	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Bladder Urothelial Carcinoma		EFO_0006544	MONDO_0005611		3.65	3.39	0.24	1.67	2.89	4.74	32.21
Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)	TCGA Primary Tumors	1088	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Breast Invasive Carcinoma		EFO_1000307	MONDO_0006256		3.6	2.84	0.06	1.67	2.81	4.72	23.46
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)	TCGA Primary Tumors	304	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma		EFO_1000162	MONDO_0006143		5.16	2.93	0.46	3.06	4.66	6.54	22.32
Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)	TCGA Primary Tumors	35	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cholangiocarcinoma		EFO_0005221	MONDO_0019087		1.56	0.89	0.21	0.88	1.32	2.07	3.49
Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)	TCGA Primary Tumors	65	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Chromophobe renal cell carcinoma		EFO_0000335	MONDO_0017885		0.31	0.45	0.02	0.11	0.18	0.28	2.56
Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)	TCGA Primary Tumors	288	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Colon Adenocarcinoma		EFO_1001949	MONDO_0002271		5.49	5.86	0.69	3.01	4.39	6.57	77.56
Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)	TCGA Primary Tumors	102	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cutaneous Melanoma		EFO_0000389	MONDO_0005012		2.25	2.09	0.04	0.72	1.66	3.34	13.44
Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)	TCGA Primary Tumors	158	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Esophageal Carcinoma		EFO_0002916	MONDO_0019086		7.57	5.34	0.27	3.94	6.16	9.26	31.38
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)	TCGA Primary Tumors	152	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		1.82	1.37	0.19	0.97	1.52	2.2	9.49
Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Head and Neck Squamous Cell Carcinoma		EFO_0000181	MONDO_0010150		3.58	2.82	0.1	1.73	2.91	4.49	24.82
Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)	TCGA Primary Tumors	369	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Hepatocellular Carcinoma		EFO_0000182	MONDO_0007256		0.82	0.84	0.04	0.28	0.52	0.99	5.44
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)	TCGA Primary Tumors	507	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		1.03	1.34	0.07	0.35	0.57	1.08	11.25
Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)	TCGA Primary Tumors	510	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Adenocarcinoma		EFO_0000571	MONDO_0005061		2.4	2.28	0.2	1.19	1.75	2.77	23.18
Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Squamous Cell Carcinoma		EFO_0000708	MONDO_0005097		3.45	2.1	0.23	1.96	3.1	4.28	13.91
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)	TCGA Primary Tumors	47	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma		EFO_0000403	MONDO_0018905		4.37	3.01	0.42	2.21	3.27	5.94	12.01
Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)	TCGA Primary Tumors	86	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Mesothelioma		EFO_0000588	MONDO_0005065		2.04	1.19	0.35	1.36	1.88	2.47	7.21
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		1.98	1.37	0.23	1.06	1.63	2.49	11.78
Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pancreatic Adenocarcinoma		EFO_1000044	MONDO_0006047		1.51	0.84	0.1	0.95	1.32	1.96	4.54
Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pheochromocytoma and Paraganglioma		EFO_0020005	MONDO_0035540		0.39	0.28	0.05	0.19	0.3	0.52	2.01
Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)	TCGA Primary Tumors	494	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Prostate Adenocarcinoma		EFO_0000673	MONDO_0005082		0.52	0.51	0.03	0.25	0.4	0.61	4.87
Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)	TCGA Primary Tumors	92	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Rectum Adenocarcinoma		EFO_0005631	MONDO_0002169		5.44	2.84	0.98	3.18	4.67	7.55	13.95
Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)	TCGA Primary Tumors	527	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Clear Cell Carcinoma		EFO_0000349	MONDO_0005005		1.34	0.95	0.01	0.74	1.18	1.74	10.35
Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)	TCGA Primary Tumors	286	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Papillary Cell Carcinoma		EFO_0000640	MONDO_0017884		0.63	0.64	0.02	0.25	0.46	0.82	5.68
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)	TCGA Primary Tumors	258	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		3.52	3.04	0.05	1.57	2.5	4.62	18.43
Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Stomach Adenocarcinoma		EFO_0000503	MONDO_0005036		5.5	7.07	0.28	2.63	4.35	6.72	122.73
Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)	TCGA Primary Tumors	148	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Testicular Germ Cell Tumor		EFO_1000566	MONDO_0010108		4.38	2.37	0.42	2.68	3.86	5.66	11.11
Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)	TCGA Primary Tumors	118	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thymoma		EFO_1000581	MONDO_0006456		3.47	2.1	0.46	1.78	3.17	4.92	12.43
Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)	TCGA Primary Tumors	501	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thyroid Carcinoma		EFO_0002892	MONDO_0015075		0.76	0.39	0.08	0.45	0.7	1.02	2.59
Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)	TCGA Primary Tumors	56	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Carcinosarcoma		EFO_1000613	MONDO_0006485		3.12	1.36	1.01	2.06	2.95	4.04	5.85
Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)	TCGA Primary Tumors	178	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Corpus Endometrial Carcinoma		EFO_0007532	MONDO_0000553		3.06	3.35	0.04	1.42	2.28	3.68	26.79
Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)	TCGA Primary Tumors	79	ENSG00000139618	BRCA2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uveal Melanoma		EFO_1000616	MONDO_0006486		0.38	0.36	0	0.11	0.25	0.6	1.54
